ecosystem / people / keith-loo
Keith Loo on the TechTO stage

Keith Loo

Co-founder & CEO, Skinopathy

Health TechTorontoOn TechTO stages since 2020

Keith Loo co-founded Skinopathy with Dr. Colin Hong in 2020 and is its CEO. The North York company builds AI tools that screen, triage and track skin conditions, aimed at Canada's shortage of dermatologists. He started it partly because of his son Logan's rare genetic condition, and told that story at TechTO in 2025.

On the TechTO stage ×1

First seen on the TechTO stage in 2020. Every talk is searchable — ask the archive about Keith

In their words

No one should lose their life or health because they couldn't get a timely assessment.

TechTO, May 2025 · watch at 02:58

When you have the why, the what and the how is solvable.

TechTO, May 2025 · watch at 06:39

When you're asking for money, which is very common for a lot of us, why don't we start first by asking for advice?

TechTO, May 2025 · watch at 07:15
A few quotes can’t cover everything Keith said on the TechTO stage. 1,600+ talks are searchable.Ask about Keith

More from TechTO ×1

Around the web ×1

Quick answers

What is Keith Loo known for?

Co-founding Skinopathy, a Toronto AI health company for skin condition screening and triage, and running it as CEO. He also teaches and advises at Schulich School of Business and BEST at Lassonde.

What did Keith Loo speak about at TechTO?

'From Patient to Innovator' in May 2025 — how Skinopathy started and how it changed access to results for patients.

Why did Keith Loo start Skinopathy?

In part because of his son Logan, who has a rare genetic condition, and because Canada's dermatologist shortage leaves patients waiting months or years.

Suggest an edit
This is you? Claim this profileAsk to be removed
Know someone who belongs here? Suggest a profile
Maintained by TechTO · facts sourced and dated · last reviewed Jul 25, 2026